nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR7—decidua—ovarian cancer	0.0176	0.178	CbGeAlD
Hydroxychloroquine—Primaquine—KRT7—ovarian cancer	0.0157	0.57	CrCbGaD
Hydroxychloroquine—TLR7—gonad—ovarian cancer	0.0155	0.157	CbGeAlD
Hydroxychloroquine—TLR7—uterus—ovarian cancer	0.0154	0.156	CbGeAlD
Hydroxychloroquine—TLR7—female reproductive system—ovarian cancer	0.0138	0.14	CbGeAlD
Hydroxychloroquine—TLR7—vagina—ovarian cancer	0.0125	0.127	CbGeAlD
Hydroxychloroquine—TLR7—testis—ovarian cancer	0.0111	0.113	CbGeAlD
Hydroxychloroquine—TLR7—lymph node—ovarian cancer	0.00808	0.0818	CbGeAlD
Hydroxychloroquine—Primaquine—CYP1B1—ovarian cancer	0.00531	0.193	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1B1—ovarian cancer	0.00451	0.164	CrCbGaD
Hydroxychloroquine—CYP2D6—female reproductive system—ovarian cancer	0.00177	0.0179	CbGeAlD
Hydroxychloroquine—CYP2D6—female gonad—ovarian cancer	0.00161	0.0163	CbGeAlD
Hydroxychloroquine—CYP2D6—testis—ovarian cancer	0.00143	0.0145	CbGeAlD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CB—ovarian cancer	0.00126	0.00352	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CD—ovarian cancer	0.00125	0.00349	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—ovarian cancer	0.00124	0.00348	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—MAPK1—ovarian cancer	0.00124	0.00347	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EREG—ovarian cancer	0.00122	0.0034	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IKBKG—ovarian cancer	0.00122	0.0034	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—ovarian cancer	0.00121	0.00338	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—ovarian cancer	0.0012	0.00335	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—MAPK3—ovarian cancer	0.00119	0.00333	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—ovarian cancer	0.00118	0.0033	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CA—ovarian cancer	0.00117	0.00329	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—ovarian cancer	0.00117	0.00327	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—ovarian cancer	0.00117	0.00327	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK3—ovarian cancer	0.00116	0.00324	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—MAPK3—ovarian cancer	0.00116	0.00324	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK3—ovarian cancer	0.00115	0.00321	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—MAPK1—ovarian cancer	0.00113	0.00317	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HSD17B6—ovarian cancer	0.00112	0.00315	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—ovarian cancer	0.00112	0.00314	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK3—ovarian cancer	0.00112	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK3—ovarian cancer	0.00112	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—ovarian cancer	0.00112	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK1—ovarian cancer	0.0011	0.00308	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—MAPK1—ovarian cancer	0.0011	0.00308	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK1—ovarian cancer	0.00109	0.00306	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ovarian cancer	0.00109	0.00305	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CB—ovarian cancer	0.00109	0.00304	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—ovarian cancer	0.00107	0.00301	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—ovarian cancer	0.00107	0.003	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—ovarian cancer	0.00107	0.00299	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK1—ovarian cancer	0.00106	0.00298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—ovarian cancer	0.00106	0.00298	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK1—ovarian cancer	0.00106	0.00298	CbGpPWpGaD
Hydroxychloroquine—Quinacrine—ABCB1—ovarian cancer	0.00106	0.0384	CrCbGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—ovarian cancer	0.00104	0.00293	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—ovarian cancer	0.00104	0.00291	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—ovarian cancer	0.00103	0.00289	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—ovarian cancer	0.00103	0.00289	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK3—ovarian cancer	0.00103	0.00288	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	0.00102	0.00284	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK3—ovarian cancer	0.001	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—ovarian cancer	0.001	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—ovarian cancer	0.001	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—ovarian cancer	0.000982	0.00275	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK1—ovarian cancer	0.000978	0.00274	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—ovarian cancer	0.000969	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	0.000966	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EREG—ovarian cancer	0.000961	0.00269	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IKBKG—ovarian cancer	0.000961	0.00269	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—ovarian cancer	0.000955	0.00268	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DLC1—ovarian cancer	0.000955	0.00268	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK1—ovarian cancer	0.000955	0.00268	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	0.000951	0.00266	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—ovarian cancer	0.000947	0.00265	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PVRL2—ovarian cancer	0.000945	0.00265	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—ABCB1—ovarian cancer	0.000936	0.0341	CrCbGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK3—ovarian cancer	0.000928	0.0026	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—ovarian cancer	0.000922	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—ovarian cancer	0.000922	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—ovarian cancer	0.000909	0.00255	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—ovarian cancer	0.000884	0.00248	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK1—ovarian cancer	0.000883	0.00247	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	0.000877	0.00246	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—ovarian cancer	0.000876	0.00245	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—ovarian cancer	0.00087	0.00244	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Topotecan—ovarian cancer	0.000868	0.00168	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Topotecan—ovarian cancer	0.000864	0.00167	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Topotecan—ovarian cancer	0.000864	0.00167	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ovarian cancer	0.000862	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PPP2R1A—ovarian cancer	0.000859	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—ovarian cancer	0.000853	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—ovarian cancer	0.000853	0.00239	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Paclitaxel—ovarian cancer	0.000853	0.00165	CcSEcCtD
Hydroxychloroquine—Urticaria—Melphalan—ovarian cancer	0.00085	0.00164	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—ovarian cancer	0.000849	0.00238	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Docetaxel—ovarian cancer	0.000848	0.00164	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—ovarian cancer	0.000846	0.00237	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—ovarian cancer	0.000846	0.00237	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Chlorambucil—ovarian cancer	0.00084	0.00162	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	0.000838	0.00235	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—ovarian cancer	0.000838	0.00235	CbGpPWpGaD
Hydroxychloroquine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000837	0.00162	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Paclitaxel—ovarian cancer	0.000837	0.00162	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—ovarian cancer	0.000834	0.00233	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity—Epirubicin—ovarian cancer	0.000833	0.00161	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000828	0.0016	CcSEcCtD
Hydroxychloroquine—Eye disorder—Paclitaxel—ovarian cancer	0.000827	0.0016	CcSEcCtD
Hydroxychloroquine—Tinnitus—Paclitaxel—ovarian cancer	0.000825	0.0016	CcSEcCtD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—ovarian cancer	0.000816	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—ovarian cancer	0.000816	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—ovarian cancer	0.000816	0.00229	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Vinorelbine—ovarian cancer	0.000812	0.00157	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PARK2—ovarian cancer	0.000807	0.00226	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000807	0.00156	CcSEcCtD
Hydroxychloroquine—Fatigue—Vinorelbine—ovarian cancer	0.000806	0.00156	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Topotecan—ovarian cancer	0.000805	0.00156	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	0.000803	0.00225	CbGpPWpGaD
Hydroxychloroquine—Pain—Vinorelbine—ovarian cancer	0.000799	0.00155	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK3—ovarian cancer	0.000794	0.00222	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Melphalan—ovarian cancer	0.000788	0.00153	CcSEcCtD
Hydroxychloroquine—Asthenia—Topotecan—ovarian cancer	0.000784	0.00152	CcSEcCtD
Hydroxychloroquine—Alopecia—Paclitaxel—ovarian cancer	0.000782	0.00151	CcSEcCtD
Hydroxychloroquine—Vomiting—Chlorambucil—ovarian cancer	0.00078	0.00151	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Docetaxel—ovarian cancer	0.00078	0.00151	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—BCL9—ovarian cancer	0.000779	0.00218	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Paclitaxel—ovarian cancer	0.000775	0.0015	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000775	0.0015	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000774	0.0015	CcSEcCtD
Hydroxychloroquine—Pruritus—Topotecan—ovarian cancer	0.000773	0.0015	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—ovarian cancer	0.000771	0.00149	CcSEcCtD
Hydroxychloroquine—Malnutrition—Paclitaxel—ovarian cancer	0.00077	0.00149	CcSEcCtD
Hydroxychloroquine—Asthenia—Melphalan—ovarian cancer	0.000768	0.00149	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—ovarian cancer	0.000766	0.00215	CbGpPWpGaD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—ovarian cancer	0.000765	0.00148	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000764	0.00148	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	0.000764	0.00214	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Melphalan—ovarian cancer	0.000757	0.00146	CcSEcCtD
Hydroxychloroquine—Tension—Paclitaxel—ovarian cancer	0.000756	0.00146	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK1—ovarian cancer	0.000755	0.00211	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Docetaxel—ovarian cancer	0.000754	0.00146	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	0.000752	0.00211	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Docetaxel—ovarian cancer	0.00075	0.00145	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—ovarian cancer	0.000749	0.00145	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000749	0.00145	CcSEcCtD
Hydroxychloroquine—Nervousness—Paclitaxel—ovarian cancer	0.000748	0.00145	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Topotecan—ovarian cancer	0.000747	0.00145	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PVRL2—ovarian cancer	0.000747	0.00209	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	0.000742	0.00208	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Vinorelbine—ovarian cancer	0.000742	0.00144	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vinorelbine—ovarian cancer	0.000739	0.00143	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vinorelbine—ovarian cancer	0.000739	0.00143	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—ovarian cancer	0.000734	0.00206	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Melphalan—ovarian cancer	0.000732	0.00142	CcSEcCtD
Hydroxychloroquine—Nausea—Chlorambucil—ovarian cancer	0.000729	0.00141	CcSEcCtD
Hydroxychloroquine—Vision blurred—Paclitaxel—ovarian cancer	0.000726	0.0014	CcSEcCtD
Hydroxychloroquine—Visual impairment—Docetaxel—ovarian cancer	0.000723	0.0014	CcSEcCtD
Hydroxychloroquine—Dizziness—Topotecan—ovarian cancer	0.000722	0.0014	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—ovarian cancer	0.00072	0.00139	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000717	0.00139	CcSEcCtD
Hydroxychloroquine—Anaemia—Paclitaxel—ovarian cancer	0.000712	0.00138	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Docetaxel—ovarian cancer	0.000709	0.00137	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—ovarian cancer	0.000709	0.00198	CbGpPWpGaD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000708	0.00137	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IKBKG—ovarian cancer	0.000708	0.00198	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EREG—ovarian cancer	0.000708	0.00198	CbGpPWpGaD
Hydroxychloroquine—Agitation—Paclitaxel—ovarian cancer	0.000708	0.00137	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000704	0.00197	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Paclitaxel—ovarian cancer	0.000704	0.00136	CcSEcCtD
Hydroxychloroquine—Eye disorder—Docetaxel—ovarian cancer	0.000701	0.00136	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000695	0.00195	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Topotecan—ovarian cancer	0.000695	0.00134	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	0.000694	0.00194	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Doxorubicin—ovarian cancer	0.000693	0.00134	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000693	0.00134	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—ovarian cancer	0.000693	0.00134	CcSEcCtD
Hydroxychloroquine—Vertigo—Paclitaxel—ovarian cancer	0.000692	0.00134	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—SKP2—ovarian cancer	0.000692	0.00194	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Paclitaxel—ovarian cancer	0.000689	0.00133	CcSEcCtD
Hydroxychloroquine—Rash—Topotecan—ovarian cancer	0.000689	0.00133	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000689	0.00133	CcSEcCtD
Hydroxychloroquine—Dermatitis—Topotecan—ovarian cancer	0.000688	0.00133	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—ovarian cancer	0.000688	0.00133	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	0.000685	0.00192	CbGpPWpGaD
Hydroxychloroquine—Headache—Topotecan—ovarian cancer	0.000684	0.00132	CcSEcCtD
Hydroxychloroquine—Vomiting—Melphalan—ovarian cancer	0.00068	0.00132	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PPP2R1A—ovarian cancer	0.000679	0.0019	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—ovarian cancer	0.000678	0.0019	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000677	0.00131	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000675	0.00131	CcSEcCtD
Hydroxychloroquine—Rash—Melphalan—ovarian cancer	0.000674	0.00131	CcSEcCtD
Hydroxychloroquine—Dermatitis—Melphalan—ovarian cancer	0.000674	0.0013	CcSEcCtD
Hydroxychloroquine—Asthenia—Vinorelbine—ovarian cancer	0.000671	0.0013	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000668	0.00129	CcSEcCtD
Hydroxychloroquine—Convulsion—Paclitaxel—ovarian cancer	0.000667	0.00129	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—ovarian cancer	0.000666	0.00129	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	0.000663	0.00186	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Docetaxel—ovarian cancer	0.000663	0.00128	CcSEcCtD
Hydroxychloroquine—Pruritus—Vinorelbine—ovarian cancer	0.000661	0.00128	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000658	0.00127	CcSEcCtD
Hydroxychloroquine—Mental disorder—Docetaxel—ovarian cancer	0.000657	0.00127	CcSEcCtD
Hydroxychloroquine—Malnutrition—Docetaxel—ovarian cancer	0.000653	0.00126	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000651	0.00126	CcSEcCtD
Hydroxychloroquine—Nausea—Topotecan—ovarian cancer	0.000649	0.00126	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—ovarian cancer	0.000645	0.00125	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—ovarian cancer	0.000641	0.00124	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vinorelbine—ovarian cancer	0.000639	0.00124	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PARK2—ovarian cancer	0.000638	0.00179	CbGpPWpGaD
Hydroxychloroquine—Ataxia—Doxorubicin—ovarian cancer	0.000636	0.00123	CcSEcCtD
Hydroxychloroquine—Nausea—Melphalan—ovarian cancer	0.000635	0.00123	CcSEcCtD
Hydroxychloroquine—Oedema—Paclitaxel—ovarian cancer	0.000629	0.00122	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—ovarian cancer	0.000626	0.00121	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000625	0.00121	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—ovarian cancer	0.000624	0.00175	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Vinorelbine—ovarian cancer	0.000618	0.0012	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000618	0.0012	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000616	0.00119	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—DOK1—ovarian cancer	0.000616	0.00172	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000615	0.00119	CcSEcCtD
Hydroxychloroquine—Skin disorder—Paclitaxel—ovarian cancer	0.000611	0.00118	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000609	0.00118	CcSEcCtD
Hydroxychloroquine—Anaemia—Docetaxel—ovarian cancer	0.000603	0.00117	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—ovarian cancer	0.0006	0.00116	CcSEcCtD
Hydroxychloroquine—Anorexia—Paclitaxel—ovarian cancer	0.000599	0.00116	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6ST—ovarian cancer	0.000598	0.00168	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Doxorubicin—ovarian cancer	0.000597	0.00115	CcSEcCtD
Hydroxychloroquine—Vomiting—Vinorelbine—ovarian cancer	0.000594	0.00115	CcSEcCtD
Hydroxychloroquine—Rash—Vinorelbine—ovarian cancer	0.000589	0.00114	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vinorelbine—ovarian cancer	0.000589	0.00114	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	0.000587	0.00164	CbGpPWpGaD
Hydroxychloroquine—Headache—Vinorelbine—ovarian cancer	0.000585	0.00113	CcSEcCtD
Hydroxychloroquine—Leukopenia—Docetaxel—ovarian cancer	0.000584	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—ovarian cancer	0.00058	0.00162	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Doxorubicin—ovarian cancer	0.000579	0.00112	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PPP1CC—ovarian cancer	0.000579	0.00162	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000577	0.00112	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Docetaxel—ovarian cancer	0.000574	0.00111	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—ovarian cancer	0.000572	0.00111	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000571	0.0016	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Docetaxel—ovarian cancer	0.000566	0.00109	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—ovarian cancer	0.000563	0.00109	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IKBKG—ovarian cancer	0.00056	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EREG—ovarian cancer	0.00056	0.00157	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Paclitaxel—ovarian cancer	0.000559	0.00108	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000559	0.00108	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—ovarian cancer	0.000555	0.00107	CcSEcCtD
Hydroxychloroquine—Nausea—Vinorelbine—ovarian cancer	0.000555	0.00107	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000552	0.00107	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—SKP2—ovarian cancer	0.000547	0.00153	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Paclitaxel—ovarian cancer	0.000546	0.00106	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000543	0.00105	CcSEcCtD
Hydroxychloroquine—Fatigue—Paclitaxel—ovarian cancer	0.000542	0.00105	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	0.000541	0.00152	CbGpPWpGaD
Hydroxychloroquine—Pain—Paclitaxel—ovarian cancer	0.000538	0.00104	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000534	0.00103	CcSEcCtD
Hydroxychloroquine—Oedema—Docetaxel—ovarian cancer	0.000533	0.00103	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—ovarian cancer	0.000529	0.00102	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—ovarian cancer	0.000526	0.00102	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Docetaxel—ovarian cancer	0.000523	0.00101	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000522	0.00101	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—ovarian cancer	0.000521	0.00101	CcSEcCtD
Hydroxychloroquine—Skin disorder—Docetaxel—ovarian cancer	0.000518	0.001	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000517	0.001	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000514	0.000995	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—ovarian cancer	0.000508	0.000984	CcSEcCtD
Hydroxychloroquine—Anorexia—Docetaxel—ovarian cancer	0.000508	0.000983	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—ovarian cancer	0.000506	0.000979	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CD—ovarian cancer	0.000505	0.00142	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PPP2R1A—ovarian cancer	0.0005	0.0014	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Paclitaxel—ovarian cancer	0.000499	0.000966	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Paclitaxel—ovarian cancer	0.000497	0.000962	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Paclitaxel—ovarian cancer	0.000497	0.000962	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—ovarian cancer	0.000493	0.00138	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Epirubicin—ovarian cancer	0.000487	0.000943	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000487	0.000942	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—ovarian cancer	0.000478	0.000926	CcSEcCtD
Hydroxychloroquine—Somnolence—Docetaxel—ovarian cancer	0.000474	0.000917	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IL6ST—ovarian cancer	0.000473	0.00132	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Epirubicin—ovarian cancer	0.000473	0.000915	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—ovarian cancer	0.000472	0.000913	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—ovarian cancer	0.00047	0.00091	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—ovarian cancer	0.000468	0.000906	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Docetaxel—ovarian cancer	0.000463	0.000896	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000463	0.000896	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00046	0.00089	CcSEcCtD
Hydroxychloroquine—Fatigue—Docetaxel—ovarian cancer	0.000459	0.000889	CcSEcCtD
Hydroxychloroquine—Pain—Docetaxel—ovarian cancer	0.000456	0.000882	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—ovarian cancer	0.000451	0.000873	CcSEcCtD
Hydroxychloroquine—Asthenia—Paclitaxel—ovarian cancer	0.000451	0.000873	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—ovarian cancer	0.000447	0.000865	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—ovarian cancer	0.000446	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—ovarian cancer	0.000446	0.00125	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Paclitaxel—ovarian cancer	0.000445	0.000861	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—ovarian cancer	0.000443	0.000858	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000443	0.000856	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MTOR—ovarian cancer	0.00044	0.00123	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CB—ovarian cancer	0.00044	0.00123	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Epirubicin—ovarian cancer	0.00044	0.000852	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HDAC6—ovarian cancer	0.000439	0.00123	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Doxorubicin—ovarian cancer	0.000437	0.000846	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—ovarian cancer	0.000436	0.000844	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000436	0.000843	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—ovarian cancer	0.000432	0.000836	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Paclitaxel—ovarian cancer	0.00043	0.000832	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—ovarian cancer	0.000428	0.000828	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Docetaxel—ovarian cancer	0.000421	0.000815	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Docetaxel—ovarian cancer	0.000421	0.000815	CcSEcCtD
Hydroxychloroquine—Dizziness—Paclitaxel—ovarian cancer	0.000416	0.000804	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—ovarian cancer	0.000415	0.000803	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—ovarian cancer	0.000414	0.0008	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1B—ovarian cancer	0.000413	0.00116	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Doxorubicin—ovarian cancer	0.00041	0.000793	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—ovarian cancer	0.000407	0.000788	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—ovarian cancer	0.000407	0.000788	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—ovarian cancer	0.000405	0.000783	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—ovarian cancer	0.0004	0.000774	CcSEcCtD
Hydroxychloroquine—Vomiting—Paclitaxel—ovarian cancer	0.0004	0.000773	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CD—ovarian cancer	0.000399	0.00112	CbGpPWpGaD
Hydroxychloroquine—Rash—Paclitaxel—ovarian cancer	0.000396	0.000767	CcSEcCtD
Hydroxychloroquine—Dermatitis—Paclitaxel—ovarian cancer	0.000396	0.000766	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—ovarian cancer	0.000396	0.000766	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—ovarian cancer	0.000396	0.000766	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PPP2R1A—ovarian cancer	0.000395	0.00111	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Epirubicin—ovarian cancer	0.000394	0.000763	CcSEcCtD
Hydroxychloroquine—Headache—Paclitaxel—ovarian cancer	0.000394	0.000762	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Docetaxel—ovarian cancer	0.000393	0.00076	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—ovarian cancer	0.000391	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—YAP1—ovarian cancer	0.000388	0.00109	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Epirubicin—ovarian cancer	0.000387	0.000749	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—ovarian cancer	0.000384	0.000743	CcSEcCtD
Hydroxychloroquine—Asthenia—Docetaxel—ovarian cancer	0.000382	0.00074	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—ovarian cancer	0.000382	0.000738	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PTEN—ovarian cancer	0.000381	0.00107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—XIAP—ovarian cancer	0.00038	0.00107	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Docetaxel—ovarian cancer	0.000377	0.000729	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—ovarian cancer	0.000377	0.000729	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—ovarian cancer	0.000374	0.000725	CcSEcCtD
Hydroxychloroquine—Nausea—Paclitaxel—ovarian cancer	0.000373	0.000723	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000372	0.00072	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SMARCA4—ovarian cancer	0.000371	0.00104	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Doxorubicin—ovarian cancer	0.000366	0.000708	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—ovarian cancer	0.000365	0.000706	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Docetaxel—ovarian cancer	0.000365	0.000705	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR4—ovarian cancer	0.000363	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EREG—ovarian cancer	0.000362	0.00101	CbGpPWpGaD
Hydroxychloroquine—Oedema—Epirubicin—ovarian cancer	0.000359	0.000695	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000358	0.000693	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—ovarian cancer	0.000353	0.000683	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—ovarian cancer	0.000353	0.000988	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Epirubicin—ovarian cancer	0.000352	0.000682	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD8A—ovarian cancer	0.000352	0.000987	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Docetaxel—ovarian cancer	0.000352	0.000682	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000352	0.000681	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—ovarian cancer	0.000349	0.000676	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IL6ST—ovarian cancer	0.000348	0.000976	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CB—ovarian cancer	0.000348	0.000975	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MTOR—ovarian cancer	0.000348	0.000975	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000344	0.000667	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—ovarian cancer	0.000343	0.000663	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—ovarian cancer	0.00034	0.000951	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PGR—ovarian cancer	0.000339	0.000949	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Docetaxel—ovarian cancer	0.000339	0.000656	CcSEcCtD
Hydroxychloroquine—Rash—Docetaxel—ovarian cancer	0.000336	0.00065	CcSEcCtD
Hydroxychloroquine—Dermatitis—Docetaxel—ovarian cancer	0.000336	0.000649	CcSEcCtD
Hydroxychloroquine—Headache—Docetaxel—ovarian cancer	0.000334	0.000646	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—ovarian cancer	0.000333	0.000643	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1B—ovarian cancer	0.000327	0.000915	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000326	0.000631	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000326	0.00063	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK3—ovarian cancer	0.000325	0.000911	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Doxorubicin—ovarian cancer	0.000323	0.000625	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—ovarian cancer	0.000319	0.000618	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—ovarian cancer	0.000317	0.000613	CcSEcCtD
Hydroxychloroquine—Nausea—Docetaxel—ovarian cancer	0.000316	0.000612	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PARP1—ovarian cancer	0.000315	0.000883	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—ovarian cancer	0.000312	0.000605	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00031	0.0006	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—ovarian cancer	0.00031	0.0006	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK1—ovarian cancer	0.000309	0.000867	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—ovarian cancer	0.000309	0.000866	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—ovarian cancer	0.000309	0.000865	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDH1—ovarian cancer	0.000308	0.000863	CbGpPWpGaD
Hydroxychloroquine—Pain—Epirubicin—ovarian cancer	0.000307	0.000595	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000303	0.000849	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—ovarian cancer	0.000301	0.000843	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000299	0.000838	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—ovarian cancer	0.000296	0.000572	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—ovarian cancer	0.000294	0.000824	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000294	0.000569	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—ovarian cancer	0.000292	0.000818	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Doxorubicin—ovarian cancer	0.000289	0.000559	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TLR4—ovarian cancer	0.000287	0.000805	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000287	0.000556	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—ovarian cancer	0.000287	0.000555	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—ovarian cancer	0.000285	0.000552	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—ovarian cancer	0.000284	0.00055	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—ovarian cancer	0.000284	0.00055	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—ovarian cancer	0.000284	0.00055	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IL6ST—ovarian cancer	0.000275	0.000771	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000272	0.000526	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—ovarian cancer	0.000269	0.000752	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—ovarian cancer	0.000268	0.000752	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—ovarian cancer	0.000265	0.000512	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—ovarian cancer	0.000264	0.000511	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—ovarian cancer	0.000263	0.000509	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—ovarian cancer	0.000263	0.000509	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ERBB2—ovarian cancer	0.00026	0.000728	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—ovarian cancer	0.000258	0.000499	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK3—ovarian cancer	0.000257	0.00072	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—ovarian cancer	0.000257	0.000718	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MTOR—ovarian cancer	0.000257	0.000718	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PPP2R1A—ovarian cancer	0.000256	0.000716	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—ovarian cancer	0.000254	0.000492	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—ovarian cancer	0.000248	0.000696	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—ovarian cancer	0.000246	0.000476	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000245	0.000474	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK1—ovarian cancer	0.000245	0.000685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—ovarian cancer	0.000245	0.000685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—ovarian cancer	0.000244	0.000682	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—ovarian cancer	0.000241	0.000674	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—ovarian cancer	0.000239	0.000462	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—ovarian cancer	0.000238	0.000666	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Epirubicin—ovarian cancer	0.000238	0.00046	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IL2—ovarian cancer	0.000236	0.00066	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—ovarian cancer	0.000235	0.000455	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—ovarian cancer	0.000233	0.000652	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—ovarian cancer	0.000231	0.000647	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—ovarian cancer	0.000228	0.000442	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—ovarian cancer	0.000228	0.00044	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—ovarian cancer	0.000227	0.000637	CbGpPWpGaD
Hydroxychloroquine—Rash—Epirubicin—ovarian cancer	0.000227	0.000438	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—ovarian cancer	0.000226	0.000438	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—ovarian cancer	0.000225	0.000436	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTEN—ovarian cancer	0.000222	0.000621	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—ovarian cancer	0.00022	0.000426	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—ovarian cancer	0.000219	0.000614	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—ovarian cancer	0.000213	0.000413	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—ovarian cancer	0.000212	0.000594	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—ovarian cancer	0.000211	0.000409	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—ovarian cancer	0.00021	0.000406	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—ovarian cancer	0.000209	0.000405	CcSEcCtD
Hydroxychloroquine—Headache—Doxorubicin—ovarian cancer	0.000208	0.000403	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ERBB2—ovarian cancer	0.000205	0.000576	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—ovarian cancer	0.000203	0.000569	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MTOR—ovarian cancer	0.000203	0.000568	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—ovarian cancer	0.000203	0.000568	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—ovarian cancer	0.000198	0.000555	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—ovarian cancer	0.000198	0.000554	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—ovarian cancer	0.000198	0.000382	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—ovarian cancer	0.000196	0.00055	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—ovarian cancer	0.00019	0.000533	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK3—ovarian cancer	0.000189	0.00053	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—ovarian cancer	0.000188	0.000526	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CAV1—ovarian cancer	0.000188	0.000526	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—ovarian cancer	0.000186	0.000522	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NME2—ovarian cancer	0.000185	0.000518	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—ovarian cancer	0.000181	0.000507	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK1—ovarian cancer	0.00018	0.000505	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—ovarian cancer	0.00018	0.000505	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—ovarian cancer	0.00018	0.000504	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6ST—ovarian cancer	0.000178	0.000499	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—ovarian cancer	0.000175	0.000491	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—ovarian cancer	0.000173	0.000486	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—ovarian cancer	0.000171	0.000479	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—ovarian cancer	0.000171	0.000479	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—ovarian cancer	0.00017	0.000477	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—ovarian cancer	0.000157	0.000439	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—ovarian cancer	0.000156	0.000438	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—ovarian cancer	0.000156	0.000438	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—ovarian cancer	0.00015	0.000421	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK3—ovarian cancer	0.00015	0.000419	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—ovarian cancer	0.000145	0.000405	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK1—ovarian cancer	0.000142	0.000399	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—ovarian cancer	0.000142	0.000399	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—ovarian cancer	0.000138	0.000388	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—ovarian cancer	0.000135	0.000377	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—ovarian cancer	0.000133	0.000372	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTOR—ovarian cancer	0.000131	0.000367	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—ovarian cancer	0.000131	0.000367	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—ovarian cancer	0.000128	0.000358	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—ovarian cancer	0.000126	0.000353	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—ovarian cancer	0.000124	0.000346	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—ovarian cancer	0.000123	0.000345	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—ovarian cancer	0.000121	0.000338	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—ovarian cancer	0.00012	0.000337	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYTB—ovarian cancer	0.000119	0.000334	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—ovarian cancer	0.000117	0.000329	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—ovarian cancer	0.000116	0.000326	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—ovarian cancer	0.000114	0.00032	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—ovarian cancer	0.000114	0.000319	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—ovarian cancer	0.000113	0.000317	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—ovarian cancer	0.000109	0.000307	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	0.000104	0.000292	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BRIP1—ovarian cancer	0.000104	0.000292	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—ovarian cancer	0.000102	0.000287	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—ovarian cancer	0.000101	0.000284	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—ovarian cancer	0.000101	0.000283	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—ovarian cancer	0.000101	0.000283	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK3—ovarian cancer	9.68e-05	0.000271	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—ovarian cancer	9.42e-05	0.000264	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK1—ovarian cancer	9.21e-05	0.000258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—ovarian cancer	9.21e-05	0.000258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—ovarian cancer	8.7e-05	0.000244	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—ovarian cancer	7.99e-05	0.000224	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—ovarian cancer	7.73e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—ovarian cancer	7.39e-05	0.000207	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—ovarian cancer	7.08e-05	0.000198	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—YAP1—ovarian cancer	6.98e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—ovarian cancer	6.53e-05	0.000183	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FASN—ovarian cancer	5.69e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.6e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.41e-05	0.000151	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.19e-05	0.000145	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.6e-05	0.000129	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.27e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMS—ovarian cancer	4.19e-05	0.000117	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.38e-05	9.46e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.08e-05	8.62e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.71e-05	7.58e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.36e-05	6.61e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.04e-05	5.71e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.44e-05	4.03e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.17e-05	3.29e-05	CbGpPWpGaD
